Endobronchial Valves in Treatment of Persistent Air Leak: European Case-Series Study and Best Practice Recommendations – From an Expert Panel

医学 胸膜成形术 泄漏 重症监护医学 保守治疗 外科 普通外科 气胸 环境工程 工程类
作者
Illaa Smesseim,Louis-Vincent Morin-Thibault,Felix J.F. Herth,James Tonkin,Pallav L. Shah,Dirk‐Jan Slebos,Theodoor David Koster,Chris Dickhoff,Johannes M. A. Daniels,Jouke Tabe Annema,Peter Iwan Bonta
出处
期刊:Respiration [Karger Publishers]
卷期号:103 (9): 544-562 被引量:15
标识
DOI:10.1159/000539573
摘要

INTRODUCTION: Persistent air leak (PAL) is associated with prolonged hospitalization, high morbidity and increased treatment costs. Conservative treatment consists of observation, chest tube drainage, and pleurodesis. Guidelines recommend surgical evaluation if air leak does not respond after 3-5 days. One-way endobronchial valves (EBV) have been proposed as a treatment option for patients with PAL in which surgical treatment is not feasible, high risk or has failed. We aimed to provide a comprehensive overview of reported EBV use for PAL and issue best practice recommendations based on multicenter experience. METHODS: We conducted a retrospective observational case-series study at four different European academic hospitals and provided best practice recommendations based on our experience. A systematic literature review was performed to summarize the current knowledge on EBV in PAL. RESULTS: We enrolled 66 patients, male (66.7%), median age 59.5 years. The most common underlying lung disease was chronic obstructive pulmonary disease (39.4%) and lung cancer (33.3%). The median time between pneumothorax and valve placement was 24.5 days (interquartile range: 14.0-54.3). Air leak resolved in 40/66 patients (60.6%) within 30 days after EBV treatment. Concerning safety outcome, no procedure-related mortality was reported and complication rate was low (6.1%). Five patients (7.6%) died in the first 30 days after intervention. CONCLUSION: EBV placement is a treatment option in patients with PAL. In this multicenter case-series of high-risk patients not eligible for lung surgery, we show that EBV placement resulted in air leak resolution in 6 out of 10 patients with a low complication rate. Considering the minimally invasive nature of EBV to treat PAL as opposed to surgery, further research should investigate if EBV treatment should be expanded in low to intermediate risk PAL patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
冯梦梦完成签到,获得积分10
刚刚
之子之远完成签到,获得积分10
刚刚
传奇3的应助被MADAO采纳,获得30
2秒前
大白完成签到 ,获得积分10
2秒前
CITY111119发布了新的文献求助10
2秒前
2秒前
2秒前
zww113发布了新的文献求助10
2秒前
3秒前
冯梦梦发布了新的文献求助10
3秒前
童童完成签到,获得积分10
4秒前
4秒前
7ian完成签到 ,获得积分10
5秒前
欢喜夏天完成签到,获得积分10
5秒前
清辉影的应助被漫漫采纳,获得10
6秒前
7秒前
等风归发布了新的文献求助10
8秒前
9秒前
昏睡的绿海完成签到,获得积分10
9秒前
AKKK完成签到 ,获得积分10
9秒前
9秒前
逆流沙完成签到,获得积分10
10秒前
FashionBoy的应助被马亚斌采纳,获得10
10秒前
839788336完成签到,获得积分10
11秒前
归帆发布了新的文献求助10
11秒前
iNk的应助被ladywerwer采纳,获得10
12秒前
NUS完成签到,获得积分10
12秒前
gentle发布了新的文献求助10
12秒前
wspqbs关注了科研通微信公众号
13秒前
xiang完成签到,获得积分10
14秒前
erlangenbio完成签到,获得积分10
14秒前
14秒前
深情安青的应助被杜欣悦采纳,获得10
15秒前
16秒前
modoun完成签到,获得积分10
17秒前
iNk的应助被ladywerwer采纳,获得10
18秒前
apricity199的应助被淘宝叮咚采纳,获得10
19秒前
吃不饱完成签到 ,获得积分10
20秒前
空城完成签到 ,获得积分20
22秒前
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181839
求助须知:如何正确求助?哪些是违规求助? 9571584
关于积分的说明 21818707
捐赠科研通 7778124
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557710
邀请新用户注册赠送积分活动 2479621